This expands the fight against the infection caused by invasive mosquito species, which could rise in Europe as average temperatures rise.
Some pediatricians have warned that the unfolding flu season could hit Europe particularly hard this winter, with younger patients having a particularly hard time.
Until now, only precautionary measures such as mosquito nets and long clothing offered protection against the dreaded tropical disease. With vaccination, the risk can be significantly reduced.
A male patient reported onset of symptoms on 25 July 2021, dying on 2 August. The case is located in the Guéckédou Prefecture, Nzérékoré Region, and is the first known case of MVD in Guinea and West Africa.
The IHR National Focal Point for the USA notified PAHO/WHO of the imported case. As of 27 July 2021 the patient is hospitalized.
The UK notified the WHO of a PCR-confirmed monkeypox case on a patient that lived and worked in Delta State, Nigeria. A second case was confirmed on 31 May 2021.
On 31 May 2021 China's National Health Commission notified WHO of one confirmed case in Zhenjiang City, Jiangsu Province. The patient is in a stable condition.
Rising cases of circulating vaccine-derived poliovirus type 2 (cVDPV2) in parallel to the wild poliovirus type 1 (WPV1) variant. The African region, Afghanistan and Pakistan are particularly affected.
Clade 2.3.4.4b of avian influenza A(H5Nx) viruses outbreak in a poultry farm in Astrakhan Oblast. First reported detection of A(H5N8) in humans. Risk of human-to-human transmission remains low.
The causal agent has not yet been identified. All cases are located in Wuhan City, Hubei Province. Close contacts are also under medical observation.
Vaccine-derived poliovirus type 2 (cVDPV2) outbreaks in Nigeria, the Lake Chad Basin (LCB) sub-region, the Democratic Republic of the Congo, Angola, Central African Republic and Horn of Africa region.
No particular variety of the virus provided. The cases are laboratory-confirmed MERS-CoV infection cases.
The circulating vaccine-derived poliovirus type 1 (cVDPV1) has affected eight provinces and the National Capital District. Five rounds of Supplementary Immunisation Activities (SIA) have been conducted.
The virus is currently focalized in the Edo and Ondo states, but with cases reported across 20 states and the Federal Capital Territory
Current virus type is the DENV3, affecting mostly the Kingston and Saint Andrew parishes.
The cases show an extensive drug resistant (XDR) Neisseria gonorrhoeae infection. They are resistant to ceftriaxone and with intermediate susceptibility to azithromycin.
Two cases were reported on January 17th, 2019. National routine oral polio vaccine type 3 immunization campaign took place in 2017.
Confirmed and probable cases in North Kivu and Ituri provinces, totaling 11 Health Zones affected.
During December 2018, the International Health Regulations National Focal Point of Saudi Arabia has reported five more cases of the Middle East Respiratory Syndrome Coronavirus.